Somatic Morbidity and Causes of Death in Hospitalized Patients with Schizophrenia

Introduction

Schizophrenia is a severe mental disorder in which physical health may receive less attention than psychiatric symptoms. Evidence consistently indicates reduced life expectancy and substantial somatic comorbidity among affected patients. Systematic assessment of physical illness and causes of death is therefore an essential component of clinical care.

Aim

To identify the most frequent somatic diseases among patients with schizophrenia and to examine diseases associated with the immediate causes of death.

Material and methods

The study included 266 patients with schizophrenia. Coexisting somatic pathology was investigated using a documentary method based on available medical information on physical morbidity and causes of death.

The design provides a clinically grounded descriptive profile of physical disease in a psychiatric population, while not establishing causal mechanisms.

Higher burden of somatic disease

The study concluded that somatic morbidity among patients with schizophrenia was higher than the national average. This finding supports routine physical-health monitoring alongside psychiatric treatment.

Diabetes mellitus as the leading registered comorbidity

Diabetes mellitus was the most frequently registered somatic disorder and occurred more often than in the general population, followed by peptic ulcer disease. The finding is clinically relevant to the established metabolic vulnerability of people with schizophrenia and the need for early detection and management of diabetes.

Lower frequency of bronchial asthma

In contrast, bronchial asthma was recorded less frequently than expected. This observation became part of a broader research line on negative comorbidity between schizophrenia and selected somatic diseases.

The finding should not be interpreted as proof of a protective mechanism; rather, it raises a clinical and pathogenetic question requiring further investigation.

Causes of death

Cerebrovascular disease was identified as the most frequent cause of death, resembling the mortality pattern in the general population. The broader conclusions from the same research programme also identify tuberculosis and cerebrovascular disease as conditions most often associated with the immediate cause of death.

These findings direct attention to vascular risk, infections and the need for integrated psychiatric and medical care.

Clinical implications

• physical health should be assessed systematically in hospitalized patients with schizophrenia;
• metabolic risk, particularly diabetes, requires active monitoring;
• cerebrovascular disease is directly relevant to premature mortality;
• psychiatric diagnosis should not lead to diagnostic overshadowing of physical illness;
• coordination between psychiatry, internal medicine and primary care is important for reducing preventable risk.

Main contributions

• describes somatic morbidity in a clinical group of 266 patients with schizophrenia;
• identifies diabetes and peptic ulcer disease as leading registered physical conditions;
• highlights the lower observed frequency of asthma as a question for subsequent research;
• connects somatic comorbidity with mortality;
• supports systematic physical-health assessment as part of psychiatric care.

Conclusions

Somatic morbidity is not a secondary issue in schizophrenia but a major component of overall health risk. The higher burden of physical disease, the prominence of diabetes and the role of cerebrovascular pathology in mortality support an integrated model of psychiatric and somatic care.

Scientific Key Terms